-
European stocks to open lower as global market optimism over U.S.-China trade progress fades
Join CNBC for live updates on European markets.
-
China's racing to build its AI chip ecosystem as U.S. curbs bite. Here's how its supply chain stacks up
U.S. export controls on Nvidia have incentivized China to develop alternatives, while also making it more difficult for domestic firms to do so, experts say.
-
Databricks says annualized revenue will reach $3.7 billion by next month
Databricks told investors and analysts on Wednesday that annualized revenue will hit $3.7 billion by July, with 50% year-over-year growth.
-
Elon Musk's favorability among Republicans dropped 16 points since March, Quinnipiac says
The Tesla CEO’s favorability scores have declined among GOP voters, according to public opinion survey results from Quinnipiac University.
-
CNBC Daily Open: There's progress on trade and U.S. inflation — but it's harder to rely on such news
When even hard numbers are suspect, we might have to navigate the path ahead a little blinder than usual.
-
PBS, NPR funding on the line as House nears final vote on $9.4 billion in DOGE-backed cuts
Passage would solidify DOGE-backed cuts, but some Republicans are uneasy about the programs being targeted, including the Corporation for Public Broadcasting.
-
Asia-Pacific markets trade mixed as investors assess Trump claims of ‘done' deal with China
Asia-Pacific markets traded mixed as traders assessed U.S. President Donald Trump’s declaration that a trade deal with China was “done.”
-
Cramer's Lightning Round: Union Pacific is a buy
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
-
Jim Cramer says IPOs to come from speculative names in space, quantum computing and nuclear power
The ‘Mad Money’ host reviewed areas where highly-speculative names are gaining traction: space, quantum computing and nuclear power.
-
Chime prices IPO at $27 per share, valuing fintech company at $11.6 billion ahead of Nasdaq debut
Chime’s debut set for Thursday follows recent listings from eToro and Circle, with investors watching closely to gauge broader appetite for fintech offerings.
-
Jim Cramer says it's time for the U.S. to negotiate with other countries for rare earth minerals
CNBC’s Jim Cramer on Wednesday said it’s necessary for the U.S. to negotiate with countries other than China for vital rare earth minerals.
-
Stock futures slip after S&P 500 ends three-day win streak: Live updates
Wednesday marked a losing session on Wall Street, with the S&P 500 snapping its three-day win streak, as did the Nasdaq Composite.
-
Shaquille O'Neal to pay $1.8 million to settle FTX investor lawsuit
Shaquille O’Neal has agreed to pay $1.8 million to settle a class action suit accusing him of misleading investors by promoting crypto exchange FTX.
-
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
The new members will join the Advisory Committee on Immunization Practices, or ACIP, which advises the Centers for Disease Control and Prevention.
-
Oracle shares climb 8% as earnings, revenue top estimates
Oracle reported better-than-expected results for the latest quarter and said it will likely deliver more revenue than it had planned for in fiscal 2029.
-
Small retailers on ‘vacation from hell' as they seek clarity on Trump's China tariffs
While President’s Trump’s 90-day tariff pause has helped boost the stock market after a brutal April, small businesses are still suffering from the uncertainty.
-
Costco is exploring options to make membership more valuable, CEO says
The basic Gold Star membership costs $65 for one year, while the premium Executive Membership costs $130.
-
Bessent floats extending tariff pause for countries in ‘good faith' trade talks
President Trump’s officials have repeatedly said they are nearing trade deals with several countries, without releasing specifics of most of them.
-
Why a Covid-19 vaccine could soon cost as much as $150—even if you're insured
Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more expensive this fall. Here’s why.
-
Chime's IPO will test public market appetite for fintech as companies line up to exit
After a multi-year IPO freeze, fintech companies like Chime are entering the public market with slashed valuations and tempered expectations.